Goldfinch Bio, A U.S.-Based, Clinical Stage Biotechnology Company Focused On Discovering And Developing Precision Medicines For The Treatment Of Kidney Diseases, Today Announced It Entered Into A License Agreement With Takeda Pharmaceutical Company Limited (
